Filing Details

Accession Number:
0000950170-25-024858
Form Type:
13D Filing
Publication Date:
2025-02-20 19:00:00
Filed By:
Perceptive Advisors
Company:
Solid Biosciences Inc. (NASDAQ:SLDB)
Filing Date:
2025-02-21
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Perceptive Advisors LLC 0 11,934,679 0 11,934,679 11,934,679 15.6%
Joseph Edelman 0 11,934,679 0 11,934,679 11,934,679 15.6%
Perceptive Life Sciences Master Fund, Ltd. 0 11,861,572 0 11,861,572 11,861,572 15.5%
Perceptive Xontogeny Venture Fund, LP 0 73,107 0 73,107 73,107 0.1%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D

 
Perceptive Advisors LLC
 
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:02/21/2025
 
Joseph Edelman
 
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:02/21/2025
 
Perceptive Life Sciences Master Fund, Ltd.
 
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Partner
Date:02/21/2025
 
Perceptive Xontogeny Venture Fund, LP
 
Signature:/s/ Joseph Edelman
Name/Title:By: Perceptive Xontogeny Venture GP, LLC By: Joseph Edelman, Managing Member
Date:02/21/2025